Drugs that contain Cupric Sulfate; Manganese Sulfate; Selenious Acid; Zinc Sulfate
1. Multrys patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11786548 | AM REGENT | Trace element compositions, methods of making and use |
Jul, 2041
(17 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Apr 30, 2024 |
NCE-1 date: 01 May, 2023
Market Authorisation Date: 30 June, 2021
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
MULTRYS family patents
2. Tralement patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11786548 | AM REGENT | Trace element compositions, methods of making and use |
Jul, 2041
(17 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Apr 30, 2024 |
NCE-1 date: 01 May, 2023
Market Authorisation Date: 30 June, 2021
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
TRALEMENT family patents